Akèy › Maladi kadyovaskilè › North Carolina › Raleigh
Etid klinik pou Maladi kadyovaskilè nan Raleigh, NC
5 etid pou Maladi kadyovaskilè ap chèche patisipan nan sit nan ak bò kote Raleigh (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Ap rekriteFaz 4
- Duke Vascular Surgery and Vein Center at Brier Creek, Raleigh
Product Surveillance Registry
Ap rekriteEtid obsèvasyon
- Raleigh, Raleigh
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Ap rekriteFaz 3
- Accellacare US Inc, Raleigh
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
Ap rekrite
- NC Heart and Vascular Research, LLC, Raleigh
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
Ap rekrite
- NC Heart and Vascular Research, LLC, Raleigh
Etid Maladi kadyovaskilè nan lòt vil
- Boston, MA37 etid
- New York City, NY33 etid
- Washington, DC28 etid
- Houston, TX24 etid
- Dallas, TX23 etid
- Atlanta, GA22 etid
- Cleveland, OH22 etid
- Chicago, IL21 etid
- Philadelphia, PA21 etid
- Pittsburgh, PA20 etid
- St. Louis, MO20 etid
- Nashville, TN18 etid
Lòt etid nan Raleigh
- Ensifizyans kadyak7 etid
- Maladi atè koronè6 etid
- Obèsite6 etid
- Dyabèt Tip 26 etid
- Degeneresans makile6 etid
- Ateroskleroz5 etid
- Sipwa5 etid
- Kansè Endomèt5 etid
- Akidan serebavaskilè5 etid
- Ensifizans renn4 etid
- Dyabèt4 etid
- Kansè ovè4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.